A cutting-edge approach to immunotherapy shows that forcing cancer cells to die through necroptosis can dramatically boost the body's anti-tumor defenses. By combining three existing drugs, scientists ...

Safety concerns included a 58% rate of treatment-related adverse events, with severe cases like immune-related colitis and a ...

The second study presented at the SITC meeting focuses on a “next-generation” approach following TIL therapy, utilizing ...

Immunotherapy—could that be an option for me, doctor?” is a question frequently asked by patients with colorectal cancer. The ...

Immunotherapy, which harnesses our body's own immune system to fight cancer, has revolutionized modern oncology. Yet despite ...

A major fund just opened a multimillion-dollar position in ImmunityBio—and the move could hint at rising confidence in this ...

A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with ...

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell ...

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune ...

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that ...

TKI-based regimens remain the primary approach for metastatic renal cell carcinoma after immune checkpoint inhibitor therapy, ...

Cancer immunology research has increasingly focused on the complex interactions between oncogenic drivers, such as KRAS mutations, and the tumor ...